EUVIMEDEUVIMED entdecken
Crossref

Copper(II) Complexes of Pyrazolopyrimidine Derivatives as Anticancer Agents with Enhanced Chemodynamic Therapy through Bimodal Apoptosis and Ferroptosis

Kun Yang, Qian Chen, Juan Chen, Lu-Fei Geng, Meng-Xue Ma, Yun-Qiong Gu, Muhammad Iqbal Choudhary, Hong Liang, Zhen-Feng Chen iD

Journal of Medicinal Chemistry · 10.04.2025 · 68 (7) · 7137-7152

DOI: 10.1021/acs.jmedchem.4c02515 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 26.03.2025. Verfasst von Kun Yang und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, Key Laboratory for Chemistry and Molecular Engineering of Medici…. Hauptthemen laut MEDLINE: Ferroptosis, Antineoplastic Agents, Copper, Apoptosis. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 79 Literaturangaben. Gefördert von: Natural Science Foundation of Guangxi Zhuang Autonomous Region, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We reported 10 new copper(II) complexes 1-10 with pyrazolopyrimidine derivatives as ligands. Complexes 2 and 4 reacted with glutathione (GSH) in cells through Fenton-like reaction to generate highly toxic hydroxyl radical (·OH) for chemodynamic therapy (CDT), and reduced endogenous glutathione peroxidase 4 (GPX4) to induce ferroptosis. In addition, these complexes effectively caused mitochondrial dysfunction and induced apoptosis and autophagy in tumor cells. Furthermore, 2 and 4 effectively inhibited the bladder cancer cell growth in a xenograft model. This study presents new copper(II) complexes that can significantly induce bladder cancer cells death by enhanced CDT through bimodal apoptosis and ferroptosis, providing a promising approach for cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisAntineoplastic AgentsCopperApoptosisPyrimidinesCoordination ComplexesPyrazolesHumansAnimalsCell Line, TumorMiceMice, NudeXenograft Model Antitumor AssaysUrinary Bladder NeoplasmsCell ProliferationStructure-Activity Relationship

Substanzen

Antineoplastic AgentsCopperPyrimidinesCoordination ComplexesPyrazoles

Autor:innen und Institutionen

  • State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources (Ministry of Education of China), School of Chemistry an…
  • International Center for Chemical and Biological Sciences, University of Karachi, Karachi 74270, Pakistan.

ORCID-Profile: Zhen-Feng Chen

Förderung

  • Natural Science Foundation of Guangxi Zhuang Autonomous Region
  • National Natural Science Foundation of China

Zitieren

APA

Yang, K., Chen, Q., Chen, J., Geng, L. F., Ma, M. X., Gu, Y. Q., Choudhary, M. I., Liang, H., & Chen, Z. F. (2025). Copper(II) Complexes of Pyrazolopyrimidine Derivatives as Anticancer Agents with Enhanced Chemodynamic Therapy through Bimodal Apoptosis and Ferroptosis. Journal of Medicinal Chemistry, 68(7), 7137-7152. https://doi.org/10.1021/acs.jmedchem.4c02515

Vancouver

Yang K, Chen Q, Chen J, Geng LF, Ma MX, Gu YQ, et al. Copper(II) Complexes of Pyrazolopyrimidine Derivatives as Anticancer Agents with Enhanced Chemodynamic Therapy through Bimodal Apoptosis and Ferroptosis. Journal of Medicinal Chemistry. 2025;68(7):7137-7152. doi:10.1021/acs.jmedchem.4c02515

BibTeX
@article{Yang2025,
  author = {Yang, Kun and Chen, Qian and Chen, Juan and Geng, Lu-Fei and Ma, Meng-Xue and Gu, Yun-Qiong and Choudhary, Muhammad Iqbal and Liang, Hong and Chen, Zhen-Feng},
  title = {Copper(II) Complexes of Pyrazolopyrimidine Derivatives as Anticancer Agents with Enhanced Chemodynamic Therapy through Bimodal Apoptosis and Ferroptosis},
  journal = {Journal of Medicinal Chemistry},
  year = {2025},
  volume = {68},
  number = {7},
  pages = {7137--7152},
  doi = {10.1021/acs.jmedchem.4c02515}
}
Kostenlos starten →